{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:24:47Z","timestamp":1790324687922,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007486","name":"Universit\u00e9 Paris-Sud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.neuropharm.2018.06.006","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T12:38:27Z","timestamp":1528288707000},"page":"283-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"PB","title":["Intranasal administration of progesterone: A potential efficient route of delivery for cerebroprotection after acute brain injuries"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9219-7300","authenticated-orcid":false,"given":"Rachida","family":"Guennoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Fr\u00e9chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Gaignard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Liere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhamid","family":"Slama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Denier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mattern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.06.006_bib1","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1523\/JNEUROSCI.0698-11.2011","article-title":"Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon\/neuron loss and improves neurological function after stroke","volume":"31","author":"Akpan","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.STR.29.1.159","article-title":"Gender-linked brain injury in experimental stroke","volume":"29","author":"Alkayed","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1471-4159.2002.00836.x","article-title":"The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions","volume":"81","author":"Anderson","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/STROKEAHA.108.540781","article-title":"Sex differences in stroke epidemiology: a systematic review","volume":"40","author":"Appelros","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/00004647-199710000-00006","article-title":"Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats","volume":"17","author":"Aronowski","year":"1997","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","article-title":"Permeability issues in nasal drug delivery","volume":"7","author":"Arora","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib7","first-page":"119","article-title":"Targeting dopamine in acute traumatic brain injury","volume":"2","author":"Bales","year":"2010","journal-title":"Open Drug Discov. J."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/cne.902510209","article-title":"Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey","volume":"251","author":"Balin","year":"1986","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.103.063222","article-title":"Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration","volume":"309","author":"Banks","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000321044","article-title":"Nasal drug delivery in humans","volume":"40","author":"Bitter","year":"2011","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib87","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(97)00063-X","article-title":"Effects of physicochemical properties and other factors on systemic nasal drug delivery","volume":"29","author":"Behl","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/ijs.12186","article-title":"Translational perspectives on perfusion-diffusion mismatch in ischemic stroke","volume":"10","author":"Campbell","year":"2015","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.STR.0000258346.68966.9d","article-title":"Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression","volume":"38","author":"Chamorro","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib13","doi-asserted-by":"crossref","first-page":"207616","DOI":"10.1155\/2014\/207616","article-title":"Progesterone attenuates experimental subarachnoid hemorrhage-induced vasospasm by upregulation of endothelial nitric oxide synthase via Akt signaling pathway","volume":"2014","author":"Chang","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib14","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in humans","volume":"30","author":"Chapman","year":"2013","journal-title":"Pharm Res"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib88","series-title":"Translational Stroke Research","first-page":"681","article-title":"Therapeutic potential of intranasal delivery of drugs and cells for stroke and other neurological diseases","author":"Chen","year":"2012"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.expneurol.2018.03.001","article-title":"Subacute intranasal administration of tissue plasminogen activator improves stroke recovery by inducing axonal remodeling in mice","volume":"304","author":"Chen","year":"2018","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.neuropharm.2018.06.006_bib89","first-page":"1322","article-title":"Advantageous nasal drug delivery system: a review","volume":"2","author":"Chhajed","year":"2011","journal-title":"IJPSR"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2003.09.013","article-title":"Serum-cortisol reflects severity and mortality in acute stroke","volume":"217","author":"Christensen","year":"2004","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal delivery: physicochemical and therapeutic aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib18","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1089\/neu.2007.0294","article-title":"Progesterone improves acute recovery after traumatic brain injury in the aged rat","volume":"24","author":"Cutler","year":"2007","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yfrne.2009.03.001","article-title":"Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration","volume":"30","author":"De Nicola","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2008.09.003","article-title":"Intranasal administration of progesterone increases dopaminergic activity in amygdala and neostriatum of male rats","volume":"157","author":"de Souza Silva","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib21","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4155\/tde.14.41","article-title":"The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview","volume":"5","author":"Djupesland","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib23","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/jcbfm.2008.17","article-title":"Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke","volume":"28","author":"Doyle","year":"2008","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2010.05.033","article-title":"Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administration","volume":"641","author":"Ducharme","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib25","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1001\/jama.1977.03280140052016","article-title":"Prognostic value of the stress response following stroke","volume":"238","author":"Feibel","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib26","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/STROKEAHA.108.541128","article-title":"Update of the stroke therapy academic industry roundtable preclinical recommendations","volume":"40","author":"Fisher","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuropharm.2015.06.002","article-title":"Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection","volume":"97","author":"Frechou","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib28","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1056\/NEJMe1503217","article-title":"Endovascular therapy for stroke\u2013it's about time","volume":"372","author":"Furlan","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12497","article-title":"Sex differences in brain mitochondrial metabolism: influence of endogenous steroids and stroke","volume":"30","author":"Gaignard","year":"2018","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/0271678X15610338","article-title":"Progesterone reduces brain mitochondrial dysfunction after transient focal ischemia in male and female mice","volume":"36","author":"Gaignard","year":"2016","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fnagi.2017.00406","article-title":"Role of sex hormones on brain mitochondrial function, with special reference to aging and neurodegenerative diseases","volume":"9","author":"Gaignard","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib32","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/brain\/awr132","article-title":"Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice","volume":"134","author":"Gibson","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/1073858409333069","article-title":"Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke?","volume":"15","author":"Gibson","year":"2009","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/brain\/awm183","article-title":"Progesterone for the treatment of experimental brain injury; a systematic review","volume":"131","author":"Gibson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pbb.2003.07.003","article-title":"Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study","volume":"76","author":"Goss","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11095-004-1191-5","article-title":"Pharmacokinetics of substrate uptake and distribution in murine brain after nasal instillation","volume":"22","author":"Graff","year":"2005","journal-title":"Pharm Res"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/jpet.108.149807","article-title":"Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke","volume":"330","author":"Hanson","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib38","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery\u2013possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib41","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1210\/en.2007-1227","article-title":"Progesterone and estrogen regulate oxidative metabolism in brain mitochondria","volume":"149","author":"Irwin","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00011-009-0032-8","article-title":"Progesterone exerts neuroprotective effects by inhibiting inflammatory response after stroke","volume":"58","author":"Jiang","year":"2009","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11011-014-9499-2","article-title":"Improving the translation of animal ischemic stroke studies to humans","volume":"30","author":"Jickling","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib44","first-page":"374098","article-title":"Successfully climbing the \"STAIRs\": surmounting failed translation of experimental ischemic stroke treatments","volume":"2012","author":"Kahle","year":"2012","journal-title":"Stroke Res. Treat."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2008.01.032","article-title":"Delayed recovery and exaggerated infarct size by post-lesion stress in a rat model of focal cerebral stroke","volume":"1201","author":"Kirkland","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-510X(01)00532-9","article-title":"Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage","volume":"187","author":"Liu","year":"2001","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(01)01982-6","article-title":"Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion","volume":"308","author":"Liu","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib49","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.nbd.2011.11.004","article-title":"Subacute intranasal administration of tissue plasminogen activator increases functional recovery and axonal remodeling after stroke in rats","volume":"45","author":"Liu","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1474-4422(11)70066-7","article-title":"Stroke and the immune system: from pathophysiology to new therapeutic strategies","volume":"10","author":"Macrez","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib51","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1523\/JNEUROSCI.5372-11.2012","article-title":"Sex differences in the brain: the not so inconvenient truth","volume":"32","author":"McCarthy","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib52","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.jcbfm.9600059","article-title":"Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection","volume":"25","author":"McCullough","year":"2005","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib53","doi-asserted-by":"crossref","first-page":"e106238","DOI":"10.1371\/journal.pone.0106238","article-title":"Subacute intranasal administration of tissue plasminogen activator promotes neuroplasticity and improves functional recovery following traumatic brain injury in rats","volume":"9","author":"Meng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/713714452","article-title":"Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier","volume":"10","author":"Minn","year":"2002","journal-title":"J.\u00a0Drug Target."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib56","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1365-2826.2011.02141.x","article-title":"Recent findings on neuroprotection against excitotoxicity in the hippocampus of female rats","volume":"23","author":"Morales","year":"2011","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib57","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbi.2014.05.015","article-title":"Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke","volume":"41","author":"Mracsko","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/jpet.107.132381","article-title":"Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins","volume":"325","author":"Nonaka","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.20741","article-title":"1,026 experimental treatments in acute stroke","volume":"59","author":"O'Collins","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib60","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib61","first-page":"288","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J.\u00a0Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2005.09.014","article-title":"Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats","volume":"197","author":"Robertson","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib63","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1126\/science.4035356","article-title":"Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications","volume":"229","author":"Sapolsky","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jsbmb.2015.11.010","article-title":"Progesterone neuroprotection: the background of clinical trial failure","volume":"160","author":"Schumacher","year":"2016","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib65","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/er.2006-0050","article-title":"Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system","volume":"28","author":"Schumacher","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pneurobio.2013.09.004","article-title":"Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors","volume":"113","author":"Schumacher","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbadis.2009.09.003","article-title":"Mitochondria, oxidative metabolism and cell death in stroke","volume":"1802","author":"Sims","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib68","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1411090","article-title":"A\u00a0clinical trial of progesterone for severe traumatic brain injury","volume":"371","author":"Skolnick","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib69","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00004647-199607000-00008","article-title":"Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures","volume":"16","author":"Smith-Swintosky","year":"1996","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib70","doi-asserted-by":"crossref","first-page":"352","DOI":"10.31887\/DCNS.2011.13.2\/dstein","article-title":"Is progesterone a worthy candidate as a novel therapy for traumatic brain injury?","volume":"13","author":"Stein","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuroscience.2011.04.013","article-title":"Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update","volume":"191","author":"Stein","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib72","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3109\/02699052.2015.1065344","article-title":"Embracing failure: what the Phase III progesterone studies can teach about TBI clinical trials","volume":"29","author":"Stein","year":"2015","journal-title":"Brain Inj."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib73","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/CIRCULATIONAHA.106.655423","article-title":"Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke","volume":"116","author":"Strbian","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib90","series-title":"German Pharm-Tox Summit ; 82nd Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and 18th Annual Meeting of Clinical Pharmacology (VKliPha), 29. February \u2013 3 March 2016, Berlin\/German","article-title":"Effects of intranasal progesterone compared to zolpidem and placebo on sleep EEG and nocturnal hormone secretion in healthy postmenopausal women","author":"Steiger","year":"2016"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib74","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib75","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.2741\/2443","article-title":"Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury","volume":"12","author":"Wei","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib76","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/jcbfm.2013.163","article-title":"Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway","volume":"34","author":"Won","year":"2014","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib77","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/jcbfm.2013.120","article-title":"Progesterone treatment for experimental stroke: an individual animal meta-analysis","volume":"33","author":"Wong","year":"2013","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib78","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.annemergmed.2006.07.932","article-title":"ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury","volume":"49","author":"Wright","year":"2007","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib79","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1177\/0091270005276201","article-title":"Steady-state serum concentrations of progesterone following continuous intravenous infusion in patients with acute moderate to severe traumatic brain injury","volume":"45","author":"Wright","year":"2005","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib80","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa1404304","article-title":"Very early administration of progesterone for acute traumatic brain injury","volume":"371","author":"Wright","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01228-7","article-title":"Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function","volume":"826","author":"Wullner","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib82","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/cc6887","article-title":"Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial","volume":"12","author":"Xiao","year":"2008","journal-title":"Crit. Care"},{"key":"10.1016\/j.neuropharm.2018.06.006_bib83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/08941930903469482","article-title":"VEGF promotes angiogenesis and functional recovery in stroke rats","volume":"23","author":"Yang","year":"2010","journal-title":"J.\u00a0Invest. Surg."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib84","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neulet.2009.06.060","article-title":"The dose-effectiveness of intranasal VEGF in treatment of experimental stroke","volume":"461","author":"Yang","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib85","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neulet.2005.07.008","article-title":"Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia","volume":"387","author":"Yu","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.06.006_bib86","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/10717544.2011.557785","article-title":"Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia","volume":"18","author":"Zhu","year":"2011","journal-title":"Drug Deliv."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830282X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830282X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:56:39Z","timestamp":1762214199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081830282X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":90,"alternative-id":["S002839081830282X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.06.006","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of progesterone: A potential efficient route of delivery for cerebroprotection after acute brain injuries","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}